Quality of t-cell response to sars-cov-2 mrna vaccine in art-treated plwh

HIGHLIGHTS

  • who: Eeva Tortellini et al. from the Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy have published the research work: Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH, in the Journal: (JOURNAL)
  • what: The authors aimed to contribute to clarifying the knowledge gaps in the understanding of the quality, magnitude, and duration of immunity to SARS-CoV-2 vaccination in PLWH, which is critical for the proper application of mitigation strategies, including additional dose strategies, as well as for vaccine design . This study . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?